Statin use improves overall survival of patients with gastric cancer after surgery and adjuvant chemotherapy in Taiwan: A nationwide matched cohort study

Pei Rung Yang, Ying Ying Tsai, Ko Jung Chen, Yao Hsu Yang, Wei Tai Shih*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

20 Scopus citations

Abstract

Background: Numerous studies have revealed that statins have antitumor effects in vivo and in vitro. However, few studies have explored the relationship between statin use and the mortality of gastric cancer (GC) patients after treatments. This study examines the relationship between statin use and the overall survival (OS) of GC patients after surgery and adjuvant chemotherapy, using data from the nationwide cohort database of Taiwan. Methods: All patients newly diagnosed with GC from 1999 to 2008 in Taiwan were identified from the Registry of Catastrophic Illness Patients Database. Through propensity score matching, statin users were matched to statin non-users at a 1:4 ratio. The relationship between statin use and the OS of patients with GC was estimated through Cox regression models. Results: The study cohort included 1835 patients with GC who had received therapies during the study period. The death numbers among statin users (defined as those who used more than 28 cumulative defined daily doses (cDDDs)) and statin non-users were 138 and 895, respectively. A dose–response association was noted between statin use and the OS of patients with GC after treatments. The adjusted hazard ratios were 0.62 (95% confidence intervals (CI), 0.50–0.78) and 0.34 (95% CI, 0.26–0.45) for statin users administered 28–167 cDDDs and >168 cDDDs, respectively, compared with no statin use (<28 cDDDs). Conclusions: This study highlights that statin use may dose-dependently improve the OS of patients with GC after surgery and adjuvant chemotherapy in Taiwan. Additional studies are required to confirm the efficacy and safety of statin use.

Original languageEnglish
Article number2055
Pages (from-to)1-11
Number of pages11
JournalCancers
Volume12
Issue number8
DOIs
StatePublished - 08 2020

Bibliographical note

Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Gastric cancer
  • National Health Insurance Research Database
  • Overall survival
  • Registry of Catastrophic Illness Patients Database
  • Statin

Fingerprint

Dive into the research topics of 'Statin use improves overall survival of patients with gastric cancer after surgery and adjuvant chemotherapy in Taiwan: A nationwide matched cohort study'. Together they form a unique fingerprint.

Cite this